PharmaEngine, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 166.9 million compared to TWD 158.26 million a year ago. Net income was TWD 80.67 million compared to TWD 165.66 million a year ago. Basic earnings per share from continuing operations was TWD 0.56 compared to TWD 1.14 a year ago. Diluted earnings per share from continuing operations was TWD 0.56 compared to TWD 1.14 a year ago.
For the six months, sales was TWD 341.03 million compared to TWD 273.91 million a year ago. Net income was TWD 177.7 million compared to TWD 241.35 million a year ago. Basic earnings per share from continuing operations was TWD 1.24 compared to TWD 1.66 a year ago. Diluted earnings per share from continuing operations was TWD 1.24 compared to TWD 1.66 a year ago.